Acrobiosystems Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 22, 2022
Share
Acrobiosystems Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 114.26 million compared to CNY 89.45 million a year ago. Revenue was CNY 114.26 million compared to CNY 89.45 million a year ago. Net income was CNY 53.5 million compared to CNY 40.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.6688 compared to CNY 0.6756 a year ago. Diluted earnings per share from continuing operations was CNY 0.6688 compared to CNY 0.6756 a year ago.
Acrobiosystems Co Ltd is a China-based company specializing in providing recombinant protein and other key biological reagent products and technical services. The Company's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The Company's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.
ACROBIOSYSTEMS CO.,LTD. 
